Michelle Callegan to Pseudomonas Infections
This is a "connection" page, showing publications Michelle Callegan has written about Pseudomonas Infections.
Connection Strength
0.383
-
Condensins are essential for Pseudomonas aeruginosa corneal virulence through their control of lifestyle and virulence programs. Mol Microbiol. 2022 04; 117(4):937-957.
Score: 0.196
-
Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest Ophthalmol Vis Sci. 1996 Mar; 37(4):534-43.
Score: 0.033
-
The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis. Jpn J Ophthalmol. 1996; 40(2):212-9.
Score: 0.032
-
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1995 Mar; 14(3):229-34.
Score: 0.030
-
Pharmacokinetic considerations in the treatment of bacterial keratitis. Clin Pharmacokinet. 1994 Aug; 27(2):129-49.
Score: 0.029
-
Pseudomonas aeruginosa keratitis in leukopenic rabbits. Curr Eye Res. 1993 May; 12(5):461-7.
Score: 0.027
-
Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1993 May; 12(5):469-73.
Score: 0.027
-
Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Invest Ophthalmol Vis Sci. 1997 Jul; 38(8):1535-42.
Score: 0.009